Quickly Spot Consensus Among the World’s Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
50%
upside
7 price targets
|
0
%
|
|
|
|
50%
upside
22 price targets
|
0
%
|
|
|
|
50%
upside
17 price targets
|
0
%
|
|
|
|
MBX
329
MBX Biosciences
MBX
$1.69B
|
50%
upside
5 price targets
|
0
%
|
|
|
50%
upside
4 price targets
|
0
%
|
|
|
|
49%
upside
7 price targets
|
0
%
|
|
|
|
49%
upside
10 price targets
|
0
%
|
|
|
|
49%
upside
9 price targets
|
0
%
|
|
|
|
49%
upside
3 price targets
|
0
%
|
|
|
|
49%
upside
11 price targets
|
0
%
|
|
|
336
Omnicell
OMCL
$1.66B
|
49%
upside
4 price targets
|
0
%
|
|
|
49%
upside
5 price targets
|
0
%
|
|
|
|
49%
upside
8 price targets
|
0
%
|
|
|
|
49%
upside
14 price targets
|
0
%
|
|
|
|
49%
upside
11 price targets
|
0
%
|
|
|
|
48%
upside
5 price targets
|
0
%
|
|
|
|
48%
upside
7 price targets
|
0
%
|
|
|
|
48%
upside
14 price targets
|
0
%
|
|
|
|
48%
upside
6 price targets
|
0
%
|
|
|
|
48%
upside
4 price targets
|
0
%
|
|
|
|
48%
upside
4 price targets
|
0
%
|
|
|
|
48%
upside
12 price targets
|
0
%
|
|
|
|
48%
upside
10 price targets
|
0
%
|
|
|
|
48%
upside
8 price targets
|
0
%
|
|
|
|
48%
upside
3 price targets
|
0
%
|
|